Summary：**Scientists Unveil Stunning Detail of Gene Regulation in Single Cells from Bulk Data** *DeepDETAIL

referrerpolicy="no-referrer"
style="max-width:100%;height:auto;display:block;margin:0 auto;">

**Scientists Unveil Stunning Detail of Gene Regulation in Single Cells from Bulk Data**
*DeepDETAILS enables cross-modality deconvolution of bulk sequencing samples.*

---

### Introduction
Researchers at the Genomic Insight Institute have announced a breakthrough that lets scientists peek inside individual cells without ever isolating them. By applying a new computational tool called DeepDETAILS to ordinary bulk‑sequencing data, the team can reconstruct the fine‑grained gene‑regulation patterns that drive cellular identity, disease states, and drug responses. The advance promises to make single‑cell‑level insight accessible to labs that lack expensive microfluidic platforms, potentially reshaping how basic and translational biology are performed.

### Key Developments
DeepDETAILS builds on recent advances in probabilistic modeling and multimodal data integration. The algorithm treats each bulk sample as a mixture of hidden cell‑type signatures, then refines those signatures using auxiliary epigenomic and proteomic datasets that are routinely generated alongside RNA‑seq. In benchmark tests on publicly available human tumor atlases, DeepDETAILS recovered cell‑type‑specific transcription factor activity with correlation scores exceeding 0.85—comparable to results obtained from true single‑cell RNA‑seq. Importantly, the method runs on a standard laptop, completing a typical 30‑million‑read dataset in under ten minutes, a speed that could democratize high‑resolution analyses across core facilities and small‑scale labs.

### Industry Analysis
The launch of DeepDETAILS arrives at a moment when the single‑cell market is projected to surpass $5 billion by 2028, driven by demand for precision oncology and immunotherapy development. Yet the high cost of droplet‑based platforms and the need for specialized expertise have limited adoption outside major sequencing centers. By extracting single‑cell resolution from bulk data, DeepDETAILS offers a cost‑effective alternative that could accelerate biomarker discovery in